Ischemic Stroke

ACCP Ischemic Stroke

ACCP GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/63243

Contents of this Issue

Navigation

Page 6 of 7

Table 4. Drugs (continued) Class/Agent (Brand) Route Injectables Anticoagulants Heparin (UFH) LMWH Enoxaparin (Lovenox® ) Subcut, (IV) FDA-approved for prophylaxis and treatment of DVT, prophylaxis of ischemic complications of unstable angina and non–Q-wave MI, and treatment of acute STEMI Dalteparin (Fragmin® ) Subcut Prophylactic deep venous thrombosis (DVT) doses Tinzaparin (Innohep® ) Subcut FDA-approved for prophylaxis of DVT, prophylaxis of ischemic complications of unstable angina and non–Q-wave MI, and extended treatment of symptomatic venous thromboembolism in patients with cancer FDA-approved for the treatment of acute symptomatic DVT with or without pulmonary embolism when administered in conjunction with warfarin sodium IV Dose Adjust to APTT Comments

Articles in this issue

Archives of this issue

view archives of Ischemic Stroke - ACCP Ischemic Stroke